You want the tightest possible glycemic management
LF contains both SNS and PNS input, and while its often hypothesized to reflect SNS activity predominantly, this is not definitive
These trials are evaluating retatrutide across several patient populations, including individuals with obesity, type 2 diabetes, and related metabolic conditions
GLP1, or glucagon-like peptide-1, is a hormone naturally produced by the body, primarily in the intestines, in response to food intake
Further, GLP-1RAs promote VSMC redifferentiation via AMPK/SIRT1/forkhead box O (FOXO3a) pathways, where the expression of contractile VSMCs markers (SM22 and Calponin) is increased [125]
doi: 10.1016/S1566-0702(00)00215-0 107 GroppEShanabroughMBorokEXuAWJanoschekRBuchTet al